Asparaginase has long been utilized in ALL chemotherapy, following the discovery of its anti-leukemic effect, mediated by serum asparagine and glutamine depletion, and clinical trials demonstrating improved survival for asparaginase-treated patients31,32. This evidence concerns the gene ASPG and acute lymphoblastic leukemia.